{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:23:36Z","timestamp":1793993016440,"version":"4.8.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Grant-in-Aid for Publication of Scientific Research Results","award":["25F096167"],"award-info":[{"award-number":["25F096167"]}]},{"name":"2024 Tokai University School of Medicine Research Aid"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>TP53 mutations play a central role in the carcinogenesis of oral squamous cell carcinoma (OSCC). However, due to the diversity of variant patterns of TP53 genetic alterations, the clinical significance of TP53 mutations in OSCC remains poorly understood. Thus, we set out to analyze all exons of the TP53 gene to characterize the TP53 mutation landscape in OSCC and to investigate its associations with clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Treatment-na\u00efve surgical specimens from 124 patients with OSCC were comprehensively analyzed for TP53 mutations using next-generation sequencing. Pathogenicity for each mutation was defined by referring to genomic databases, OncoKB and ClinVar. Multivariable Cox regression analysis was performed to assess the association between the presence of TP53 pathogenic mutations and cancer-specific survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TP53 pathogenic mutations were detected in 81\/124 (65%) OSCC cases, comprising 75 different variant patterns. OSCC patients harboring TP53 pathogenic mutations showed shorter cancer-specific survival compared to those without pathogenic mutations (multivariable hazard ratio, 3.70; 95% confidence interval, 1.08\u201312.61). Moreover, cases with truncating and\/or splice mutations showed worse outcomes than other mutation types. Among OSCC patients with stage III\/IV, the presence of TP53 pathogenic mutations was significantly associated with shorter survival (P\u00a0=\u00a00.001), whereas no such association was observed in stage I\/II patients (P\u00a0=\u00a00.89).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TP53 pathogenic mutations in OSCC have been associated with shorter cancer-specific survival, especially for advanced diseases. Our findings likely attest to the importance of TP53-based molecular classification, leading to the development of novel precision strategies against OSCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jjco\/hyag056","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:44:09Z","timestamp":1775043849000},"page":"837-848","source":"Crossref","is-referenced-by-count":1,"title":["<i>TP53<\/i>\n                    mutation landscape and patient survival in oral squamous cell carcinoma"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3737-4769","authenticated-orcid":false,"given":"Mebae","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]},{"name":"Department of Pathology, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Carreras","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Nagase","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Hoshimoto","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Uchibori","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Masugi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tokai University School of Medicine , 143 Shimokasuya, Isehara, Kanagawa 259-1193,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"2026070605422782800_ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026070605422782800_ref2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3892\/or.2023.8599","article-title":"Mutant p53 in head and neck squamous cell carcinoma: molecular mechanism of gain-of-function and targeting therapy (review)","volume":"50","author":"Li","year":"2023","journal-title":"Oncol Rep"},{"key":"2026070605422782800_ref3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"The Cancer Genome Atlas Network","year":"2015","journal-title":"Nature"},{"key":"2026070605422782800_ref4","doi-asserted-by":"publisher","first-page":"e006666","DOI":"10.1136\/jitc-2023-006666","article-title":"TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma","volume":"11","author":"Shi","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2026070605422782800_ref5","doi-asserted-by":"publisher","first-page":"15507","DOI":"10.1016\/j.prp.2023.155071","article-title":"Clinical and pathological correlation of P53 expression in oral cancers","volume":"253","author":"Bellala Ravishankar","year":"2024","journal-title":"Pathol Res Pract"},{"key":"2026070605422782800_ref6","first-page":"2889","article-title":"P53 protein expression in oral squamous cell carcinoma: survival analysis","volume":"21","author":"Gonzalez-Moles","year":"2001","journal-title":"Anticancer Res"},{"key":"2026070605422782800_ref7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/0973-029X.180922","article-title":"Immunohistochemical expression of p53 and its clinicopathological correlation with modified Anneroth's histological grading system","volume":"20","author":"Dave","year":"2016","journal-title":"J Oral Maxillofac Pathol"},{"key":"2026070605422782800_ref8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s13104-018-3547-7","article-title":"Immunohistochemical overexpression of p53 in head and neck squamous cell carcinoma: clinical and prognostic significance","volume":"11","author":"Hashmi","year":"2018","journal-title":"BMC Res Notes"},{"key":"2026070605422782800_ref9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12663-009-0051-6","article-title":"Histological significance of p53 gene expression in squamous cell carcinoma of the buccal mucosa","volume":"8","author":"Jayade","year":"2009","journal-title":"J Maxillofac Oral Surg"},{"key":"2026070605422782800_ref10","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1245\/s10434-019-07287-x","article-title":"All-exon TP53 sequencing and protein phenotype analysis accurately predict clinical outcome after surgical treatment of head and neck squamous cell carcinoma","volume":"26","author":"Kobayashi","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"2026070605422782800_ref11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13005-017-0138-0","article-title":"Site-specific gene expression patterns in oral cancer","volume":"13","author":"Frohwitter","year":"2017","journal-title":"Head Face Med"},{"key":"2026070605422782800_ref12","doi-asserted-by":"publisher","DOI":"10.14639\/0392-100X-2336","article-title":"Long-term disease-free survival in surgically resected oral tongue cancer: a 10-year retrospective study","volume":"39","author":"Marra","year":"2019","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2026070605422782800_ref13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/bjc.2017.244","article-title":"Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis","volume":"117","author":"Almangush","year":"2017","journal-title":"Br J Cancer"},{"key":"2026070605422782800_ref14","doi-asserted-by":"publisher","first-page":"20776","DOI":"10.1038\/s41598-022-25291-2","article-title":"Value of p53 sequencing in the prognostication of head and neck cancer: a systematic review and meta-analysis","volume":"12","author":"Basyuni","year":"2022","journal-title":"Sci Rep"},{"key":"2026070605422782800_ref15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: state of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int J Oral Sci"},{"key":"2026070605422782800_ref16","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1007\/s00784-019-03189-0","article-title":"Analysis of risk factors for multiple primary oral squamous cell carcinoma: a cohort study","volume":"24","author":"Lin","year":"2020","journal-title":"Clin Oral Investig"},{"key":"2026070605422782800_ref17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.oraloncology.2017.06.013","article-title":"Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: primary surgical resection vs nonsurgical treatment","volume":"71","author":"Fujiwara","year":"2017","journal-title":"Oral Oncol"},{"key":"2026070605422782800_ref18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ijom.2010.12.003","article-title":"Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma","volume":"40","author":"Oliveira","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2026070605422782800_ref19","doi-asserted-by":"publisher","first-page":"20160270","DOI":"10.1098\/rstb.2016.0270","article-title":"Epstein\u2013Barr virus infection and nasopharyngeal carcinoma","volume":"372","author":"Tsao","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2026070605422782800_ref20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3892\/ijmm.2024.5448","article-title":"TP53 mutations in cancer: molecular features and therapeutic opportunities (review)","volume":"55","author":"Tornesello","year":"2025","journal-title":"Int J Mol Med"},{"key":"2026070605422782800_ref21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40291-013-0020-0","article-title":"TP53 testing and Li-Fraumeni syndrome: current status of clinical applications and future directions","volume":"17","author":"Sorrell","year":"2013","journal-title":"Mol Diagn Ther"},{"key":"2026070605422782800_ref22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"p53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"2026070605422782800_ref23","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1093\/nar\/gkm744","article-title":"Two faces of p53: aging and tumor suppression","volume":"35","author":"Rodier","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"2026070605422782800_ref24","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1101\/gad.340976.120","article-title":"p53 tetramerization: at the center of the dominant-negative effect of mutant p53","volume":"34","author":"Gencel-Augusto","year":"2020","journal-title":"Genes Dev"},{"key":"2026070605422782800_ref25","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1074\/jbc.M208528200","article-title":"A stable human p53 heterotetramer based on constructive charge interactions within the tetramerization domain","volume":"278","author":"Brokx","year":"2003","journal-title":"J Biol Chem"},{"key":"2026070605422782800_ref26","doi-asserted-by":"publisher","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026070605422782800_ref27","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nature08489","article-title":"Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution","volume":"461","author":"Shah","year":"2009","journal-title":"Nature"},{"key":"2026070605422782800_ref28","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.2011.473","article-title":"Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML","volume":"305","author":"Link","year":"2011","journal-title":"JAMA"},{"key":"2026070605422782800_ref29","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"2026070605422782800_ref30","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.1206923","article-title":"Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1","volume":"333","author":"Agrawal","year":"2011","journal-title":"Science"},{"key":"2026070605422782800_ref31","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1158\/1078-0432.CCR-14-0565","article-title":"Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2026070605422782800_ref32","volume-title":"TNM classification of malignant tumours","author":"Brierley","year":"2017","edition":"8th"},{"key":"2026070605422782800_ref33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3322\/caac.21389","article-title":"Head and neck cancers: major changes in the American joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Lydiatt","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2026070605422782800_ref34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.oooo.2021.10.004","article-title":"Automatic discrimination of Yamamoto-Kohama classification by machine learning approach for invasive pattern of oral squamous cell carcinoma using digital microscopic images: a retrospective study","volume":"133","author":"Yoshizawa","year":"2022","journal-title":"Oral Dis"},{"key":"2026070605422782800_ref35","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/s41379-018-0024-y","article-title":"Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia","volume":"31","author":"Sawada","year":"2018","journal-title":"Mod Pathol"},{"key":"2026070605422782800_ref36","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of p53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"2026070605422782800_ref37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2026070605422782800_ref54","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"","year":"2013","journal-title":"Sci Signal"},{"key":"2026070605422782800_ref55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"2026070605422782800_ref38","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/annonc\/mdy011","article-title":"A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma","volume":"29","author":"Li","year":"2018","journal-title":"Ann Oncol"},{"key":"2026070605422782800_ref39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"2026070605422782800_ref40","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/cancers13040790","article-title":"Mutant p53 gain-of-function: role in cancer development, progression, and therapeutic approaches","volume":"13","author":"Alvarado-Ortiz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026070605422782800_ref41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: new functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"2026070605422782800_ref42","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.3390\/cancers13164088","article-title":"The function of the mutant p53-R175H in cancer","volume":"13","author":"Chiang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026070605422782800_ref43","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"2026070605422782800_ref44","doi-asserted-by":"publisher","first-page":"100614","DOI":"10.1016\/j.modpat.2024.100614","article-title":"Abnormal p53 immunohistochemical patterns are associated with regional lymph node metastasis in oral cavity squamous cell carcinoma at time of surgery","volume":"37","author":"Lin","year":"2024","journal-title":"Cancers"},{"key":"2026070605422782800_ref45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.oraloncology.2017.07.002","article-title":"Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy","volume":"72","author":"Quinlan-Davidson","year":"2017","journal-title":"Oral Oncol"},{"key":"2026070605422782800_ref46","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1186\/bcr2329","article-title":"Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model","volume":"11","author":"Gunaratna","year":"2009","journal-title":"Breast Cancer Res"},{"key":"2026070605422782800_ref47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00428-023-03676-6","article-title":"Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas","volume":"485","author":"Haan","year":"2024","journal-title":"Virchows Arch"},{"key":"2026070605422782800_ref48","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4132\/jptm.2020.06.01","article-title":"Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer","volume":"54","author":"Hwang","year":"2020","journal-title":"J Pathol Transl Med"},{"key":"2026070605422782800_ref49","doi-asserted-by":"publisher","first-page":"26191","DOI":"10.1038\/srep26191","article-title":"Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing","volume":"6","author":"Cole","year":"2016","journal-title":"Sci Rep"},{"key":"2026070605422782800_ref50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000109717","article-title":"Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma","volume":"79","author":"Salinas-S\u00e1nchez","year":"2007","journal-title":"Urol Int"},{"key":"2026070605422782800_ref51","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3324\/haematol.2021.279998","article-title":"Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas","volume":"107","author":"Jovanovic","year":"2022","journal-title":"Haematologica"},{"key":"2026070605422782800_ref52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/path.5157","article-title":"Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer","volume":"246","author":"K\u00f6bel","year":"2018","journal-title":"J Pathol"},{"key":"2026070605422782800_ref53","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1038\/ncomms3873","article-title":"Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently mutated genes and molecular subgroups","volume":"4","author":"India Project Team of the International Cancer Genome Consortium","year":"2013","journal-title":"Nat Commun"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/7\/837\/68079448\/hyag056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/7\/837\/68079448\/hyag056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:42:35Z","timestamp":1783330955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/7\/837\/8653900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4,14]]},"published-print":{"date-parts":[[2026,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyag056","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,4,14]]}}}